Cardiac Rhythm Management

Introduction to Escape Beats

Escape beats are a protective cardiac rhythm that occurs when the primary pacemaker of the heart fails or slows significantly, allowing a secondary pacemaker site to take over and prevent asystole, as stated by the American College of Cardiology 1
Escape beats are a physiological safety mechanism that prevents prolonged cardiac standstill when the normal pacemaker activity is suppressed or blocked, according to the American College of Cardiology 1

Escape beats can arise from the AV junction (junctional escape) or the ventricles (ventricular escape) depending on the level of the block, as noted by the American College of Cardiology 1
The site of origin of the escape rhythm is critically important for prognosis, with escape rhythms originating from the AV node tend to be more reliable and faster, while infranodal escape rhythms are typically slower and less reliable, as reported by the American Heart Association, with evidence from Circulation 2 and the American College of Cardiology 3
The ventricles rely on an escape rhythm originating from pacemaker cells below the level of the block, which is typically slower than the sinus rhythm, usually 20-40 beats per minute if originating from the ventricles or 40-60 beats per minute if from the AV junction, as defined by the American College of Cardiology/American Heart Association 4

Escape beats signal a problem with the heart's primary pacemaker or conduction system, indicating conduction system disease, as stated by the American Heart Association, with evidence from Circulation 2
The characteristics of escape beats help determine the need for permanent pacing, with a Class I indication for permanent pacing existing for third-degree and advanced second-degree AV block with documented periods of asystole ≥3.0 seconds or escape rate <40 bpm, as recommended by the American Heart Association, with evidence from Circulation 2
High-risk features requiring urgent intervention in complete AV block include escape rhythm <40 beats/min, documented asystole ≥3.0 seconds, symptomatic bradycardia, congestive heart failure, and need for medications that suppress escape pacemakers, as recommended by the American College of Cardiology 5, 6

The ECG in complete AV block shows P waves occurring at a regular rate, representing normal atrial depolarization, QRS complexes occurring at a slower, independent rate, and no relationship between P waves and QRS complexes (AV dissociation), with more P waves than QRS complexes per unit time, as described by the American College of Cardiology/American Heart Association 4
The location of the block affects prognosis and management, with blocks at the AV node typically having a more reliable and faster escape rhythm compared to infranodal blocks, as stated by the American College of Cardiology/American Heart Association 4
The site of block is essential to identify, with narrow QRS escape rhythm indicating a block likely at the AV node or His bundle, and wide QRS escape rhythm suggesting a block within or below the His bundle, as stated by the American College of Cardiology and the American Heart Association 7, 8

Permanent pacemaker implantation is recommended as a Class I indication for all patients with complete heart block, with DDD or DDDR pacing mode typically preferred, as recommended by the American College of Cardiology 5, 6, 9
Cardiac resynchronization therapy should be considered if left ventricular dysfunction is present in patients undergoing permanent pacemaker implantation, as suggested by the American College of Cardiology 5, 6
Alternating bundle branch block implies unstable conduction disease and requires permanent pacing due to high risk of developing complete AV block, as stated by the American College of Cardiology 6
In patients with atrial fibrillation/flutter and complete heart block, permanent pacing is recommended if bradycardia is unrelated to digitalis or drugs known to impair AV conduction, as recommended by the American College of Cardiology 5
In children with third-degree AV block, the decision for permanent pacing is based on escape loci and heart rate, symptoms associated with bradycardia, and for newborns, the ability to feed without signs of hemodynamic compromise, as recommended by the American Heart Association 10

AV nodal blocking agents, such as IV beta-blockers and non-dihydropyridine calcium channel blockers, can be used to control heart rate in patients with atrial flutter, with a target heart rate initially <110 bpm, as recommended by the American Heart Association, with a strength of evidence based on moderate-quality studies 11
Electrical cardioversion has a high success rate (>95%) for converting atrial flutter to sinus rhythm, as reported by the American College of Cardiology, with a strong recommendation based on high-quality evidence 11
Anticoagulation is recommended for 3 weeks before and 4 weeks after cardioversion in patients with atrial flutter duration ≥48 hours or unknown, as suggested by the American College of Cardiology, with a strong recommendation based on high-quality evidence 11
Avoid AV nodal blocking agents in patients with pre-excitation syndromes, such as Wolff-Parkinson-White syndrome, as they may accelerate ventricular rate and precipitate ventricular fibrillation, as warned by the American College of Cardiology and the American Heart Association, with a strong warning based on high-quality evidence 11, 12

Assessing hemodynamic stability is crucial, and if unstable, temporary transcutaneous pacing and IV atropine 0.5mg every 3-5 minutes (maximum 3mg) should be considered as a bridging measure, according to the American Heart Association 13
Routine follow-up is necessary to ensure proper device function after pacemaker implantation, and any underlying cardiac conditions should be addressed, as recommended by the American College of Cardiology and the American Heart Association 6, 10
Patients with complete AV block resulting from distal disease require arrhythmia monitoring until a pacemaker is implanted due to risk of sudden death, as recommended by the American Heart Association 10